Age Labs is a Norwegian life science company that discovers, develops and commercializes diagnostic tests for the early detection of age-related diseases. Our pipeline includes a test for early detection of rheumatoid arthritis, a biological age predictor and a test predicting the severity of COVID-19 infection. Our service includes developing biomarkers for use in clinical trials and studying epigenetic drug effects.
Age Labs provides biomarker development and comprehensive reports on epigenetic drug effects for use in clinical trials.
Our main customers are companies from the pharmaceutical and nutraceutical industry.